IonQ (Nasdaq: IONQ) Live: Full Day Earnings Coverage

IonQ is up 1.50% since dropping earnings in afterhours trading. Conference call currently underway.

$IONQ (IonQ) #earnings are out: pic.twitter.com/ski5TdEweP

— The Earnings Correspondent (@earnings_guy) May 7, 2025

Commercial Expansion

• $22M deal with EPB: Sale of Forte Enterprise system & launch of first-ever quantum computing + networking hub in Chattanooga, TN.

• Pending acquisition of Lightsynq: Will bring quantum memory tech and Harvard research team—critical to future quantum internet development.

• Closed acquisition of ID Quantique (quantum-safe networking leader) and announced plan to acquire Capella (classified signals platform).

• DARPA selection: Invited to participate in Quantum Benchmarking Initiative—a major nod from U.S. government.

Technology Milestones

• Ansys demo: Showed 12% speed improvement over classical computing simulating a heart pump using quantum data.

• Next-gen ion trap vacuum system: Enables room temperature, miniaturized quantum systems with extreme vacuum levels.

• High-speed multi-species logic gates: Paving way for faster, scalable, distributed quantum networking.

• Quantum error correction: Released new codes optimized for IonQ’s long-chain trapped-ion architecture.

Outlook for 2025

• Full-year revenue guidance: $75M–$95M

• Q2 revenue forecast: $16M–$18M

IonQ continues to trade as a long-duration tech bet, and expectations are centered around R&D milestones more than financials. The market will likely focus on updates to its quantum roadmap (particularly AQ64 and future systems), federal contract momentum, and commentary on customer scaling. A soft print may be overlooked if forward outlook strengthens.

Bull Case:
IonQ bulls view it as the front-runner in commercial quantum computing, with real revenue ($66.9M in 2024) and growing government partnerships. Morgan Stanley analysts noted IonQ and IBM are the only two generating meaningful revenue in the space. Backed by DARPA, involved in the $2.5B Quantum Leadership Act, and with a product pipeline leading to AQ64, the TAM could explode. Its target price sits at $40, vs. a current price of ~$29, implying 31% upside.

Bear Case:
The bear case is rooted in commercialization risk and cash burn. IonQ lost $32M in EBITDA last quarter, and its full profitability path is unclear. Citron and others argue that at current valuations, it prices in multiple years of future growth with little margin for error. Quantum remains a long game—and the timeline is still “a big debate,” as one Morgan Stanley analyst noted.

The spotlight is squarely on execution against its ambitious roadmap. While the company is guiding for revenue of $6.5 to $7.5 million—still modest in absolute terms—the real story lies in quantum system performance and the forward-looking AQ64 chip, which aims to push the envelope of algorithmic qubit performance by 2026.

Management has emphasized rapid scaling, noting the company is already delivering 35-algorithmic-qubit “Forte” systems to commercial and government customers. IonQ’s position as the only publicly traded quantum pure play continues to attract attention from institutional and strategic partners, especially after being selected for the DARPA Quantum Benchmarking Program and further integrating with platforms like Amazon Braket and Microsoft Azure Quantum.

The company ended 2024 with $66.9M in total bookings, crushing prior guidance and suggesting a growing backlog of enterprise and federal demand. That momentum will need to continue, particularly as peers like Rigetti and D-Wave look to regain relevance.

Today’s earnings call will be less about beating consensus and more about reaffirming IonQ’s execution credibility—and whether it remains the front-runner in the race toward commercially viable quantum computing.

IonQ remains pre-commercial in terms of revenue scale, but analysts are watching closely for signs of growing bookings and quantum adoption.

• Q1 2025 Revenue Estimate: $7.6 million

• Q1 2025 EPS Estimate: –$0.18

• Q1 2025 EBITDA Estimate: –$36 million

• FY 2025 Revenue Forecast: $36–38 million

• Total FY Bookings Target: $90–100 million

What matters most here is momentum — not margin. The Street will focus on: new customer logos, any increased clarity on delivery of new QPUs, and whether IonQ can hit its stated goal of revenue-generating system installs by 2026. The company remains non-GAAP unprofitable and will continue to fund operations through its ~$336 million cash reserve.

1. DARPA Quantum Benchmarking – First Signs of Institutional Validation
Any mention of initial feedback or milestones from this government-sponsored quantum initiative could add credibility and near-term relevance to IonQ’s tech.

2. AQ64 Roadmap Check – Still 2026? Or Sooner?
Markets are baking in AQ64 for early 2026. If IonQ suggests they’re ahead of schedule—or drops new performance milestones—this could shift valuation sentiment substantially.

3. International & Supply Chain Exposure – Cost Watch
Geopolitical volatility is increasing scrutiny of high-tech supply chains. Management commentary on input cost pressure or export control risks (especially re: China) could catch investor attention.

IonQ stock is trading down 1.0% so far on the day.

But the stock is still up 237% over the past year, making it one of the most explosive early-stage tech names of 2024. The company’s valuation — $7.06 billion — reflects investor optimism not in current revenue (just over $7M expected this quarter), but in its quantum computing roadmap.

 Investors continue to bet that trapped-ion QPUs will outperform rival architectures in the race toward fault-tolerant, error-corrected quantum computing.

 Today’s earnings will be all about future projections and little to do with quarterly financials — commentary around commercialization, defense contracts, and QPU deployment timelines could reaccelerate the narrative.